Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study.
van der Sangen NMR, Küçük IT, Sivanesan S, Appelman Y, Ten Berg JM, Verburg A, Azzahhafi J, Arkenbout EK, Kikkert WJ, Pisters R, Jukema JW, Arslan F, van 't Hof A, Ilhan M, Hoebers LP, van der Schaaf RJ, Damman P, Woudstra P, van de Hoef TP, Bax M, Anthonio RL, Polad J, Adriaenssens T, Dewilde W, Zivelonghi C, Laanmets P, Majas R, Dijkgraaf MGW, Claessen BEPM, Henriques JPS. van der Sangen NMR, et al. Among authors: sivanesan s. Am Heart J. 2023 Nov;265:114-120. doi: 10.1016/j.ahj.2023.07.011. Epub 2023 Jul 28. Am Heart J. 2023. PMID: 37517430 Free article. Clinical Trial.
Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.
Azzahhafi J, van den Broek WWA, Chan Pin Yin DRPP, van der Sangen NMR, Sivanesan S, Bofarid S, Peper J, Claassens DMF, Janssen PWA, Harmsze AM, Walhout RJ, Tjon Joe Gin M, Nicastia DM, Langerveld J, Vlachojannis GJ, van Bommel RJ, Appelman Y, van Schaik RHN, Henriques JPS, Kikkert WJ, Ten Berg JM. Azzahhafi J, et al. Among authors: sivanesan s. JACC Cardiovasc Interv. 2024 Jul 29:S1936-8798(24)00913-0. doi: 10.1016/j.jcin.2024.06.020. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 39217531
Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition - a case based review.
Renkens MPL, Coerkamp CF, Witte LS, Sivanesan S, Nurmohamed NS, Westerterp M, Serruys P, Onuma Y, Grundeken MJ, Kalkman DN, Beijk M, Vis MM, Henriques JPS, Delewi R, Stroes E, Wykrzykowska JJ, de Winter RJ, Claessen BEPM. Renkens MPL, et al. Among authors: sivanesan s. Expert Rev Cardiovasc Ther. 2024 Aug;22(8):353-366. doi: 10.1080/14779072.2024.2387678. Epub 2024 Sep 11. Expert Rev Cardiovasc Ther. 2024. PMID: 39258965 Free article. Review.
Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome.
van den Broek WWA, Azzahhafi J, Chan Pin Yin DRPP, van der Sangen NMR, Sivanesan S, Dijksman LM, Walhout RJ, Gin MTJ, Breet NJ, Langerveld J, Vlachojannis GJ, van Bommel RJ, Appelman Y, van Schaik RHN, Henriques JPS, Kikkert WJ, Ten Berg JM. van den Broek WWA, et al. Among authors: sivanesan s. Eur Heart J Cardiovasc Pharmacother. 2024 Nov 13:pvae087. doi: 10.1093/ehjcvp/pvae087. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39537191
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore.
Chee CE, Khara JS, Cheong J, Fong J, Sivanesan S, Choy JY, Hu M, Viswambaram A, Toh HC. Chee CE, et al. Among authors: sivanesan s. Expert Rev Pharmacoecon Outcomes Res. 2024 Jun;24(5):631-641. doi: 10.1080/14737167.2024.2319607. Epub 2024 May 22. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38776431
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore.
Lim EH, Lim A, Khara JS, Cheong J, Fong J, Sivanesan S, Griffiths M, New E, Lee SC. Lim EH, et al. Among authors: sivanesan s. Expert Rev Pharmacoecon Outcomes Res. 2024 Mar;24(3):413-426. doi: 10.1080/14737167.2023.2295474. Epub 2024 Jan 30. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38289042 Free article.
153 results